support@activebiopharma.com
中文版
Menu
Home
Products
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF Chemicals
About Us
Custom Synthesis
Order & Payment
Contact Us
Cas Index 4
Home
/
Cas Index 4
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CAS
Chemical Name
Cat.No.
MolFormula
471905-41-6
MK-0752/MK0752
ABP000306
C21H21ClF2O4S
422513-13-1
Hesperadin/
ABP000303
C29H32N4O3S.ClH
461054-93-3
Ko 143/Ko143
ABP000297
C26H35N3O5
402957-28-2
VX-950(Telaprevir)
ABP000273
C36H53N7O6
405554-55-4
SB590885(GSK2118436)/SB-590885/GSK-2118436
ABP000264
C27H27N5O2
426219-53-6
TAK-700/TAK700
ABP000263
C18H17N3O2
425386-60-3
LY450139(Semagacestat) /LY-450139/Semagacestat
ABP000262
C19H27N3O4
479543-46-9
VX-702/VX702
ABP000258
C19H12F4N4O2
488832-69-5
Elesclomol/STA-4783
ABP000242
C19H20N4O2S2
486460-32-6
Sitagliptin/
ABP000233
C16H15F6N5O
497259-23-1
TPPB
ABP000221
C27H30F3N3O3
475489-16-8
NVP-AEW541/AEW541
ABP000220
C27H29N5O
468740-43-4
BMS-536924/BMS536924
ABP000159
C25H26ClN5O3
404950-80-7
LBH-589/Panobinostat /LBH589
ABP000143
C21H23N3O2
414864-00-9
Belinostat/PXD101,PX105684/
ABP000140
C15H14N2O4S
475150-69-7
BAN ORL 24HCL
ABP000130
C27H35N3O2
475111-38-7
1H-Benzimidazole,1-[4-chloro-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-
ABP000095
C15H13ClF2N6O
475110-96-4
ZSTK474/ZSTK-474/
ABP000085
C19H21F2N7O2
477575-56-7
PHA-665752
ABP000082
C32H34Cl2N4O4S.H2O
« Pre
50
51
52
53
54
55
56
Next »
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll